- Home
- KIND vs MGTX Comparison
KIND vs MGTX Comparison
Compare KIND & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- MGTX
- Stock Information
- Founded
- KIND 2011
- MGTX 2015
- Country
- KIND United States
- MGTX United States
- Employees
- KIND N/A
- MGTX N/A
- Industry
- KIND Computer Software: Programming Data Processing
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KIND Technology
- MGTX Health Care
- Exchange
- KIND Nasdaq
- MGTX Nasdaq
- Market Cap
- KIND 608.3M
- MGTX 622.0M
- IPO Year
- KIND N/A
- MGTX N/A
- Fundamental
- Price
- KIND $1.88
- MGTX $8.37
- Analyst Decision
- KIND Buy
- MGTX Strong Buy
- Analyst Count
- KIND 4
- MGTX 2
- Target Price
- KIND $2.56
- MGTX $24.00
- AVG Volume (30 Days)
- KIND 2.3M
- MGTX 563.1K
- Earning Date
- KIND 08-07-2025
- MGTX 08-11-2025
- Dividend Yield
- KIND N/A
- MGTX N/A
- EPS Growth
- KIND N/A
- MGTX N/A
- EPS
- KIND N/A
- MGTX N/A
- Revenue
- KIND $248,306,000.00
- MGTX $34,508,000.00
- Revenue This Year
- KIND $1.66
- MGTX $228.65
- Revenue Next Year
- KIND $10.87
- MGTX $145.06
- P/E Ratio
- KIND N/A
- MGTX N/A
- Revenue Growth
- KIND 12.01
- MGTX 203.23
- 52 Week Low
- KIND $1.32
- MGTX $3.85
- 52 Week High
- KIND $3.00
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- KIND 60.19
- MGTX 62.96
- Support Level
- KIND $1.63
- MGTX $8.32
- Resistance Level
- KIND $2.50
- MGTX $8.95
- Average True Range (ATR)
- KIND 0.13
- MGTX 0.40
- MACD
- KIND 0.02
- MGTX -0.07
- Stochastic Oscillator
- KIND 31.11
- MGTX 52.16
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.